Cointime

Reliant Pharmaceuticals

company

About

Reliant Pharmaceuticals provides cardiovascular pharmaceutical products.

  • 501 - 1000

Highlights

Total Funding Amount
$115M
Funding Rounds
1
Investors
2

Details

Last Funding Type
Series D
Last Funding Money Raised
$115M
Industries
Biotechnology,Health Care,Health Diagnostics,Pharmaceutical
Founded date
Jan 1, 1999
Number Of Employee
501 - 1000
Operating Status
Active

Reliant Pharmaceuticals provides cardiovascular pharmaceutical products. It is engaged in the sale and marketing of these products.


Its product portfolio includes Axid, a nizatidin; InnoPran XL and DynaCirc CR for the treatment of hypertension; Omacor to reduce high triglycerides; and Rythmol SR.


It provides products for the treatment of elevated cholesterol and triglycerides, acid reflux disease, and prevention of coronary complications in patients with coronary heart disease.


It distributes its products to physicians engaged in primary care, cardiovascular, and specialized medical areas.


Reliant Pharmaceuticals was established in 1999, headquartered in Liberty Corner, New Jersey.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$115M
Reliant Pharmaceuticals has raised a total of $115M in funding over 2 rounds. Their latest funding was raised on Oct 1, 2003 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 1, 2003 Series D $115M 2 Invemed Catalyst Fund — Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Reliant Pharmaceuticals is funded by 2 investors. Invemed Catalyst Fund and BayStar Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Invemed Catalyst Fund Yes Series D
BayStar Capital — Series D
Cointime
Content
Company